GT197854594A - Vacuna contra haemophilus influenzae - Google Patents

Vacuna contra haemophilus influenzae

Info

Publication number
GT197854594A
GT197854594A GT197854594A GT197854594A GT197854594A GT 197854594 A GT197854594 A GT 197854594A GT 197854594 A GT197854594 A GT 197854594A GT 197854594 A GT197854594 A GT 197854594A GT 197854594 A GT197854594 A GT 197854594A
Authority
GT
Guatemala
Prior art keywords
haemophilus influenzae
fpr
combined
vaccine
influenzae vaccine
Prior art date
Application number
GT197854594A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT197854594A publication Critical patent/GT197854594A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

UN METODO PARA LA AISLACION DEL POLISACARIDO ANTIGENO FOSFATO DE POLIRIBOSIL RIBITOL (FPR) A PARTIR DE CULTIVOS DE HAEMOPHILUS INFLUENZAE TIPO B; Y UN PROCEDIMIENTO PARA LA PRE PARACION DE UNA VACUNA COMBINADA QUE CONTIENE ANTIGENOS DE FPR Y B PERTUSSIS, COMBINADO TAMBIEN CON OTRAS CEPAS NO PATOGENAS DE BACTERIAS, PARA DESCARGAR UNA RESPUESTA DE ANTICUERDO EN ANIMALES DE SANGRE CALIENTE. VACUNA CONTRA LA MENINGI TIS.
GT197854594A 1977-10-28 1978-10-11 Vacuna contra haemophilus influenzae GT197854594A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/846,466 US4196192A (en) 1977-10-28 1977-10-28 Combined Haemophilus influenzae type b and pertussis vaccine

Publications (1)

Publication Number Publication Date
GT197854594A true GT197854594A (es) 1980-04-03

Family

ID=25298023

Family Applications (1)

Application Number Title Priority Date Filing Date
GT197854594A GT197854594A (es) 1977-10-28 1978-10-11 Vacuna contra haemophilus influenzae

Country Status (2)

Country Link
US (1) US4196192A (es)
GT (1) GT197854594A (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5097020A (en) * 1983-07-05 1992-03-17 The University Of Rochester Immunogenic conjugates
US4673574A (en) * 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US5360897A (en) * 1981-08-31 1994-11-01 The University Of Rochester Immunogenic conjugates of streptococcus pneumonial capsular polymer and toxin or in toxiad
US4902506A (en) * 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
US4474758A (en) * 1981-11-19 1984-10-02 American Cyanamid Company Haemophilus influenzae type b and pertussis outer membrane component combined vaccine
US4496538A (en) * 1982-07-06 1985-01-29 Connaught Laboratories, Inc. Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine
US4644059A (en) * 1982-07-06 1987-02-17 Connaught Laboratories, Inc. Haemophilus influenzae B polysaccharide-diptheria toxoid conjugate vaccine
US4761283A (en) * 1983-07-05 1988-08-02 The University Of Rochester Immunogenic conjugates
US4762713A (en) * 1983-07-05 1988-08-09 The University Of Rochester Boosting of immunogenic conjugate vaccinations by unconjugated bacterial capsular polymers
US4808700A (en) * 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
US5643565A (en) * 1985-09-20 1997-07-01 Chiron Corporation Human IL-2 as a vaccine adjuvant
US5503841A (en) * 1985-09-20 1996-04-02 Cetus Oncology Corporation Human IL-2 as a vaccine adjuvant
US5039610A (en) * 1989-06-12 1991-08-13 Merck & Co., Inc. Process for removing bacterial endotoxin from gram-negative polysaccharides
US5045456A (en) * 1989-06-12 1991-09-03 Merck & Co., Inc. Process for removing bacterial endotoxin from gram-negative polysaccharides
PL178578B1 (pl) * 1993-03-23 2000-05-31 Smithkline Beecham Biolog Zawiesina cząstek 3-0-deacylowanego monofosforylolipidu A i sposób jej wytwarzania oraz kompozycja szczepionki zawierającej antygen w połączeniu z 3-0-deacylowanym monofosforylolipidem A i sposób jej wytwarzania
US7250494B2 (en) * 1998-06-15 2007-07-31 Biosynexus Incorporated Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
CN102653565A (zh) * 2011-03-03 2012-09-05 天津康希诺生物技术有限公司 一种从荚膜细菌发酵液纯化荚膜多糖的方法
CN104558225B (zh) * 2014-12-11 2017-02-22 云南沃森生物技术股份有限公司 一种针对肠道细菌的荚膜多糖提取方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2461439C3 (de) * 1974-12-24 1980-03-20 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines schützenden Antigens von Bordetella Pertussis sowie jenes enthaltendes Mittel

Also Published As

Publication number Publication date
US4196192A (en) 1980-04-01

Similar Documents

Publication Publication Date Title
GT197854594A (es) Vacuna contra haemophilus influenzae
Comstock et al. Tuberculosis studies in Muscogee County, Georgia: VII. A twenty-year evaluation of BCG vaccination in a school population
BR9610802A (pt) Método para melhoria da resposta imunológica método de preparo de células t de antígeno específico método para induzir tolerância de tecido de enxerto auxiliar de vacina meio de expansão e preparação de células dentríticas população de células dentríticas e respectivo método de preparo método para direcionar células-tronco hematopoiéticas ou células progenitoras a uma linhagem de células dentríticas
ES8801318A1 (es) Un procedimiento para la produccion de un peptido.
ES500567A0 (es) Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos.
ES469225A1 (es) Procedimiento para potenciar la accion de las vacunas.
Cvjetanovic Field trial of typhoid vaccines
GB1522006A (en) Feline calicivirus vaccine and a process for the production thereof
Hildemann et al. Relationship between skin transplantation immunity and the formation of humoral isoantibodies in mice
ATE15693T1 (de) Zellkultur-verfahren.
ES469937A1 (es) Procedimiento para preparar una nueva cepa del virus de la rabia.
ES8401722A1 (es) Procedimiento de obtencion de vacunas contra el patogeno h influenzae tipo b.
DE68916424D1 (de) Pasteurella-impfstoff.
Ximénez et al. Resistance to Nocardia brasiliensis infection in mice immunized with either Nocardia or BCG
ES355121A1 (es) Procedimiento para la preparacion de una vacuna libre de antigenos.
ES8304801A1 (es) Un metodo para preparar una vacuna contra vibrio anguillarum
ATE21484T1 (de) An menschliche fibroblastenzellen adaptierte hepatitis-a-viren.
Wu et al. Effect of a stimulating dose of pertussis vaccine on children previously immunized
Levin et al. Cellular immunity in Peyer's patches of rats infected with Trichinella spiralis
McKinnon et al. Interpretation of reactions following revaccination
FR2330409A1 (fr) Procede de preparation d'un nouveau vaccin antileptospirose monovalent, et vaccin ainsi obtenu
ATE206138T1 (de) Helicobacter pylori antigen
Stones Isolation of ECHO virus type 9 during an outbreak of meningo-encephalitis
Okuda et al. Immunologic cross-reactivity of Escherichia coli B envelope glycoproteins with some animal and plant cell membrane proteins
UA18970A (uk) Спосіб виготовлеhhя тест-системи для серологічhої експрес-діагhостики туберкульозу